TACHOSIL
TACHOSIL
Approved
DIN Number
02439026
Drug Class
Human
Market Date
N/A
Company
HC
Corza Medical GmbH
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02439026
AIG Number0356730001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
B02BC30 COMBINATIONS
Product Specifications
Dosage FormPatch
Route of AdministrationTopical
AHFS Classification20:28.16
Health Canada Classification
ACTIVE INGREDIENTS (3)
COLLAGENActive
Strength: 2.1 MG / SQ CM
Monograph: COLLAGEN
FIBRINOGEN (HUMAN)Active
Strength: 5.5 MG / SQ CM
Monograph: FIBRINOGEN (HUMAN)
THROMBIN (HUMAN)Active
Strength: 2 UNIT / SQ CM
Monograph: THROMBIN (HUMAN)